Compare · DHR vs QSI
DHR vs QSI
Side-by-side comparison of Danaher Corporation (DHR) and Quantum-Si Incorporated (QSI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and QSI operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $126.67B, about 661.0x QSI ($191.6M).
- Over the past year, DHR is down 9.4% and QSI is down 53.2% - DHR leads by 43.8 points.
- DHR has been more active in the news (12 items in the past 4 weeks vs 4 for QSI).
- DHR has more recent analyst coverage (25 ratings vs 4 for QSI).
- Company
- Danaher Corporation
- Quantum-Si Incorporated
- Price
- $179.03+0.46%
- $0.88-5.03%
- Market cap
- $126.67B
- $191.6M
- 1M return
- +3.27%
- -10.97%
- 1Y return
- -9.35%
- -53.16%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 12
- 4
- Recent ratings
- 25
- 4
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Quantum-Si Incorporated
Quantum-Si incorporated operates first next-generation protein sequencing and genomics platform for healthcare industries. It offers a single molecule detection solution to decode the molecules of life, including sample preparation, single molecule, massively parallel, and protein identification. The company's technology has the applications in proteomics, single cell, transcriptomics, genomics, metabolomics, and drug testing and screening fields. The company is based in Guilford, Connecticut. Quantum-Si incorporated is a subsidiary of 4Catalyzer Corporation.
Latest DHR
- Danaher Schedules Second Quarter 2026 Earnings Conference Call
- Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSM® to Help Identify Respiratory Risk Sooner
- SEC Form 11-K filed by Danaher Corporation
- Piper Sandler initiated coverage on Danaher with a new price target
- Danaher Completes Acquisition of Masimo Corporation
- SEC Form S-8 filed by Danaher Corporation
- Sirius XM Holdings Set to Join S&P MidCap 400
- Danaher Corporation filed SEC Form 8-K: Other Events
- DZ Bank initiated coverage on Danaher with a new price target
- Wolfe Research resumed coverage on Danaher
Latest QSI
- Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SEC Form 25-NSE filed by Quantum-Si Incorporated
- Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
- Quantum-Si Announces the Expansion of the Proteus™ Roadshow
- SEC Form SD filed by Quantum-Si Incorporated
- SEC Form 4 filed by Director Jafri Amir
- SEC Form 4 filed by Director Makes Brigid
- SEC Form 4 filed by Director Kenny John P.
- SEC Form 4 filed by Director Dowdy Paula
- SEC Form 4 filed by Director Fattori Ruth A